Fund Universe

Spruce Street Capital LP

CIK 0002050194 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.552
AUM ($M)
510
Positions
30
Turnover
0.17
Top-10 wt
70%
Herfindahl
0.063
History (qtrs)
3
Excess Return

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 33 positions · portfolio value $510M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
KNSA funds › KINIKSA PHARMACEUTICALS INTL ADD 11.5% +2.7% 58.7 918,070 +157,007 2
RLAY funds › RELAY THERAPEUTICS INC HOLD 11.0% +3.8% 55.8 2,984,125 +0 2
LBRX funds › LB PHARMACEUTICALS INC HOLD 8.8% +0.7% 44.7 1,376,159 +0 2
RLMD funds › RELMADA THERAPEUTICS INC ADD 8.7% -1.7% 44.2 6,391,328 +129,214 2
ANRO funds › ALTO NEUROSCIENCE INC ADD 7.0% +0.0% 35.7 1,353,047 +27,837 2
DNTH funds › DIANTHUS THERAPEUTICS INC TRIM 6.8% -0.7% 34.6 354,816 -18,458 2
ALKS funds › ALKERMES PLC ADD 5.6% +2.9% 28.5 543,876 +225,884 2
SVRA funds › SAVARA INC ADD 4.2% -0.3% 21.3 3,452,576 +69,401 2
PCVX funds › VAXCYTE INC ADD 3.5% +0.1% 17.8 306,047 +60,338 2
ELVN funds › ENLIVEN THERAPEUTICS INC HOLD 3.3% +0.2% 16.7 329,006 +0 2
ENTA funds › ENANTA PHARMACEUTICALS INC ADD 3.1% +0.3% 15.9 1,088,731 +156,133 2
CATX funds › PERSPECTIVE THERAPEUTICS INC ADD 2.5% -0.2% 12.6 3,693,931 +1,066,824 2
IFRX funds › INFLARX NV NEW 2.4% +2.4% 12.0 5,352,198 +5,352,198 1
SRZN funds › SURROZEN INC HOLD 2.2% -0.8% 11.2 432,040 +0 2
ALMS funds › ALUMIS INC HOLD 2.2% +0.1% 11.0 392,574 +0 2
IPSC funds › CENTURY THERAPEUTICS INC HOLD 2.0% -0.3% 9.9 4,059,054 +0 2
NERV funds › MINERVA NEUROSCIENCES INC HOLD 1.8% -0.6% 9.2 1,655,500 +0 2
SABS funds › SAB BIOTHERAPEUTICS INC HOLD 1.7% -0.3% 8.6 2,198,502 +0 2
ANTX funds › AN2 THERAPEUTICS INC HOLD 1.6% +0.2% 8.0 1,661,073 +0 2
ERAS funds › ERASCA INC HOLD 1.5% -0.1% 7.7 422,543 +0 2
IKT funds › INHIBIKASE THERAPEUTICS INC HOLD 1.4% -0.0% 7.3 3,581,603 +0 2
RACC funds › RESEARCH ALLIANCE CORP III NEW 1.0% +1.0% 5.3 500,000 +500,000 1
HLXC funds › HELIX ACQUISITION CORP III HOLD 1.0% -0.2% 5.3 500,000 +0 2
ZLAB funds › ZAI LAB LTD NEW 1.0% +1.0% 5.3 279,110 +279,110 1
ACHV funds › ACHIEVE LIFE SCIENCE INC NEW 0.9% +0.9% 4.8 736,637 +736,637 1
LXEO funds › LEXEO THERAPEUTICS INC HOLD 0.8% -0.4% 4.3 928,593 +0 2
ALEC funds › ALECTOR INC HOLD 0.8% -0.3% 4.2 2,101,068 +0 2
LONA funds › LEONABIO INC HOLD 0.7% -0.2% 3.6 393,701 +0 2
CRVS funds › CORVUS PHARMACEUTICALS INC HOLD 0.7% -0.1% 3.5 231,585 +0 2
JATT funds › JATT II ACQUISITION CORP NEW 0.4% +0.4% 1.8 160,000 +160,000 1
MAZE funds › MAZE THERAPEUTICS INC EXIT 0.0% -1.4% 0.0 0 -200,000 0
CUSIP:152309100 funds › CENTESSA PHARMACEUTICALS EXIT 0.0% -4.7% 0.0 0 -489,849 0
CUSIP:483497103 funds › KALVISTA PHARMACEUTICALS EXIT 0.0% -4.3% 0.0 0 -897,681 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 510 30 0.17 70% 0.063 0.551 in
2026Q1 416 28 0.40 66% 0.055 0.124 entered
2025Q4 303 27 0.00 71% 0.069 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status